Community-owned database empowers individuals with cryptocurrency for contributing genomic data SAN DIEGO — Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, announced $2 Million in Seed funding today. The round included several individual investors and former executives from Illumina ILMN 0.34%, the world leader in DNA sequencing and […]

The first >1Mb DNA sequence (more than a million DNA bases in one continuous sequence) has been achieved using Oxford Nanopore sequencing technology, a landmark in the history of DNA sequencing. Martin Smith, a researcher at the Kinghorn Centre for Clinical Genomics (at the Garvan Institute, Australia), has sequenced the first single fragment of DNA […]

UK / Chinese Collaboration to Develop Innovative Technologies for Epigenetic Analysis Porvair Sciences are teaming up with Suzhou Tianlong Bio Technology Co Ltd (China), together with Swansea University and Xi’an Jiaotong University in a collaborative project entitled, “Automating & Stratification of Epigenetics in Healthcare” that is part of the Innovate UK / Jiangsu Industrial Challenge Programme. The […]

The UK’s world-class expertise in the research of biofilms was recognised through the recent launch of the new National Biofilms Innovation Centre (NBIC). Supported by a commitment of £26 million over the next 5 years, including £12.5M funding from the Biotechnology and Biological Sciences Research Centre (BBSRC) and Innovate UK, with additional support from universities, industry […]

First Product Release from Inscripta’s Enzyme Engineering Platform Boulder, Colo. – In a huge step forward for innovation in the cutting-edge field of CRISPR gene-editing, Inscripta – a gene-editing technology company – announced today that it is releasing one of its own, unique CRISPR enzymes, which will be free for all researchers to use. Called […]

Aldevron and Integrated DNA Technologies, Inc. (IDT), a supplier of custom nucleic acid and genome editing products, have announced a license agreement whereby Aldevron will manufacture and distribute a S. pyogenes Cas9 variant—known as SpyFiTM Cas9 Nuclease—which is patented by IDT. The product will be manufactured for research, clinical, and commercial use. “IDT continues to be an innovator for the […]

SAN DIEGO—Illumina, Inc. (NASDAQ:ILMN) today announced Aimee Hoyt, an accomplished and strategic talent leader, will head its human resources team. Ms. Hoyt will join as Senior Vice President and Chief People Officer (CPO), starting January 8, 2018, and will be responsible for leading all aspects of the company’s HR strategies, reporting to the CEO. This press release features multimedia. […]

Phasefocus continues to increase its global international profile with the appointment of Nuohai Life Sciences as the company’s exclusive distributor for mainland China, Hong Kong and Macau. Nuohai Life Sciences will provide sales, service and technical support for the Livecyte™ Cell Imaging System throughout the region, building on their reputation for introducing innovative new technologies […]

Orgenesis and Pall Corporation originally received BIRD Grant in 2015 to co-develop a viral transduction production process for the treatment of diabetes. GERMANTOWN, Md. — Orgenesis Ltd., a wholly-owned subsidiary of Orgenesis Inc., (OTCQB:ORGSD) (“Orgenesis” or the “Company”), a vertically-integrated biopharmaceutical company with expertise and unique experience in gene and cell therapy and regenerative medicine, […]